Abstract
α2-Macroglobulin (α2M) is an extracellular chaperone that inhibits amorphous and fibrillar protein aggregation. The reaction of α2M with proteases results in an 'activated' conformation, where the proteases become covalently-linked within the interior of a cage-like structure formed by α2M. This study investigates, the effect of activation on the ability of α2M to inhibit amyloid formation by Aβ1-42 and I59T human lysozyme and shows that protease-activated α2M can act via two distinct mechanisms: (i) by trapping proteases that remain able to degrade polypeptide chains and (ii) by a chaperone action that prevents misfolded clients from continuing along the amyloid forming pathway. Structured summary of protein interactions: Aβ1-42 and Aβ1-42 bind by fluorescence technology (View interaction)I59T lysozyme and I59T lysozyme bind by light scattering (View interaction)I59T lysozyme and I59T lysozyme bind by fluorescence technology (View interaction)Alpha-lactalbumin and Alpha-lactalbumin bind by fluorescence technology (View interaction)I59T lysozyme and I59T lysozyme bind by electron microscopy (View interaction)Aβ1-42 and Aβ1-42 bind by electron microscopy (View interaction).
Original language | English |
---|---|
Pages (from-to) | 398-403 |
Number of pages | 6 |
Journal | FEBS Letters |
Volume | 587 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1 Mar 2013 |
Keywords
- α -Macroglobulin
- Aβ
- Amyloid disease
- Extracellular chaperone
- Human lysozyme